While industry representatives welcomed the move to provide duty-free access to Indian goods, the exclusion of the CDSCO from the regulatory recognition framework is flagged as a concern and prompted calls for reconsideration.
from Top Health News | Latest Healthcare Sector & Healthcare Industry news, Information and Updates: ET HealthWorld : ETHealthworld.com https://ift.tt/Xbu5vFl
Home »
Information and Updates: ET HealthWorld : ETHealthworld.com
,
Top Health News | Latest Healthcare Sector & Healthcare Industry news
,
IFTTT
» MedTech sees trade upside in India–NZ FTA; missing regulatory recognition a concern